Trexquant Investment’s Clearside Biomedical CLSD Stock Holding History

Trexquant Investment’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,918	Closed	-$263K	–	1339
2021 Q3	$263K	Buy	+2,918	New	+$258K	0.02%	810
2018 Q4	–	Sell	-2,036	Closed	-$188K	–	1059
2018 Q3	$188K	Buy	+2,036	New	+$242K	0.01%	837
2018 Q1	–	Sell	-2,391	Closed	-$251K	–	1108
2017 Q4	$251K	Buy	+2,391	New	+$257K	0.03%	823
2017 Q1	–	Sell	-713	Closed	-$96K	–	1104
2016 Q4	$96K	Buy	+713	New	+$179K	0.02%	905

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $127M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's CLSD Position: Q4 2021 in Review

Trexquant Investment sold out of Clearside Biomedical (CLSD) in Q4 2021, closing a stake of 2,918 shares — an estimated $263K sold.

Trexquant Investment first reported a position in CLSD in Q4 2016 and held it in 4 quarters. The position peaked at $263K in Q3 2021. 67 funds tracked by Wall St. Rank hold CLSD as of Q4 2021.

Trexquant Investment reported no remaining Clearside Biomedical position as of Q4 2021 after selling out during the quarter.
Trexquant Investment sold 2,918 Clearside Biomedical shares in Q4 2021, an estimated $263K.
Trexquant Investment first reported a position in Clearside Biomedical in Q4 2016 and held it in 4 quarters.
Trexquant Investment's Clearside Biomedical position peaked at $263K in Q3 2021.
67 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2021.

Based on Trexquant Investment's 13F filing for Q4 2021, filed 14 Feb 2022.